GCM
CRBU icon

Graham Capital Management’s Caribou Biosciences CRBU Stock Holding History

Graham Capital Management’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$73.6K Sell
38,751
-68,502
-64% -$118K ﹤0.01% 1070
2025
Q4 		$171K Sell
107,253
-21,099
-16% -$44.3K ﹤0.01% 1077
2025
Q3 		$299K Buy
+128,352
New +$242K ﹤0.01% 858
2025
Q2 		– Sell
-74,225
Closed -$67.8K – 1338
2025
Q1 		$67.8K Buy
+74,225
New +$96.5K ﹤0.01% 1225

Other funds holding CRBU

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Graham Capital Management's CRBU Position: Q1 2026 in Review

Graham Capital Management reduced its Caribou Biosciences (CRBU) stake by 64% in Q1 2026, selling an estimated $118K and leaving 38,751 shares worth $73.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1070.

Graham Capital Management first reported a position in CRBU in Q1 2025 and has held it in 4 quarters since. The position peaked at $299K in Q3 2025. 137 funds tracked by Wall St. Rank hold CRBU as of Q1 2026.

  • Graham Capital Management held 38,751 shares of Caribou Biosciences worth $73.6K as of Q1 2026.
  • Graham Capital Management sold 68,502 Caribou Biosciences shares in Q1 2026, an estimated $118K.
  • Caribou Biosciences made up ﹤0.01% of Graham Capital Management's portfolio in Q1 2026, its #1070 holding.
  • Graham Capital Management first reported a position in Caribou Biosciences in Q1 2025 and has held it in 4 quarters since.
  • Graham Capital Management's Caribou Biosciences position peaked at $299K in Q3 2025.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q1 2026.

Based on Graham Capital Management's 13F filing for Q1 2026, filed 15 May 2026.